People

Bruce Hellman

Bruce Hellman is Eye2Gene’s current named commercial advisor, supporting strategy, business development and go-to-market with pharma/biotech clients. Its2026issuer introduction identifies him as founder of clinical-trial software company uMotif, which he developed through SeriesB, and an Imperial College Business School MBA. His adviser relationship is not a personal investment or director appointment.